首页 > 最新文献

Journal of Infection and Chemotherapy最新文献

英文 中文
Updated lineage information for echovirus 11 pediatric cases in Japan in 2024. 2024年日本埃可病毒11例儿科病例的最新谱系信息。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-12 DOI: 10.1016/j.jiac.2026.102949
Takuma Ohnishi, Rie Tanaka, Kyoko Tomioka, Haruki Imaizumi, Hayato Ehara, Tsuyoshi Kishimoto, Ryohei Nomoto, Ai Mori, Kousaku Matsubara, Tatsuki Ikuse, Isamu Kamimaki
{"title":"Updated lineage information for echovirus 11 pediatric cases in Japan in 2024.","authors":"Takuma Ohnishi, Rie Tanaka, Kyoko Tomioka, Haruki Imaizumi, Hayato Ehara, Tsuyoshi Kishimoto, Ryohei Nomoto, Ai Mori, Kousaku Matsubara, Tatsuki Ikuse, Isamu Kamimaki","doi":"10.1016/j.jiac.2026.102949","DOIUrl":"10.1016/j.jiac.2026.102949","url":null,"abstract":"","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"102949"},"PeriodicalIF":1.5,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147458135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Coronavirus Disease 2019 Clinical Characteristics in a Primary Emergency Medical Center: Comparative Analysis of BA.1/BA.2, BA.5/BQ.1, and XBB Periods. 某基层急诊医疗中心2019年小儿冠状病毒病临床特征:BA.1/BA的比较分析2, BA.5 / BQ。1、XBB期。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-09 DOI: 10.1016/j.jiac.2026.102948
Hiroshi Yamaguchi, Tomohiro Sameshima, Kazumichi Fujioka, Tomoko Horinouchi, Yoshitaka Asagai, Hiroki Ohashi, Tomoko Fujikawa, Akihiro Nishimura, Akihiro Tamura, Shingo Ishimori, Kandai Nozu, Masaaki Kugo, Akihito Ishida

Background: Differences in the clinical manifestation of pediatric coronavirus disease 2019 (COVID-19) across Omicron variants in emergency departments (EDs) remain unclear.

Patients and methods: This retrospective observational study characterized the clinical features of pediatric patients with COVID-19 for each variant period at a primary ED in Kobe City, Japan. The variant-dominant periods comprised BA.1/BA.2 (sixth wave, January-June 2022), BA.5/BQ.1 (seventh-eighth waves, July 2022-March 2023), and XBB (ninth wave, April-December 2023). COVID-19 was diagnosed by rapid antigen testing.

Results: Among the 46,719 pediatric ED visits, 4,085 were COVID-19 cases; 599 (9.0%), 2,943 (15.4%) and 543 (2.6%) cases were diagnosed in the sixth, seventh-eighth, and ninth waves, respectively. During the XBB period, cough was significantly more frequent than in other periods and nasal discharge was more common compared with the BA.5/BQ.1 period. Vomiting occurred more frequently in the BA.5/BQ.1 period than in the BA.1/BA.2 period. Among children aged <1 year, vomiting was significantly more common during the XBB period. No significant differences were observed between patients aged 1-4 years. Dyspnea was more common in the BA.1/BA.2 than in the BA.5/BQ.1 period. In adolescents, fever occurred more frequently during the BA.5/BQ.1 period.

Conclusion: This study compared pediatric COVID-19 cases across the BA.1/BA.2, BA.5/BQ.1, and XBB waves. Although evidence for the XBB wave remains limited, upper respiratory symptoms such as nasal discharge and cough were observed more frequently during this period. Distinct differences in clinical presentations according to variant type and age group were identified.

背景:小儿冠状病毒病2019 (COVID-19)在急诊科(EDs)不同基因组变异的临床表现差异尚不清楚。患者和方法:本回顾性观察性研究描述了日本神户市一所初级急诊科儿童COVID-19患者各变异期的临床特征。变优期为BA.1/BA.2(第六期,2022年1 - 6月),BA.5/BQ.1(第七至第八波,2022年7月至2023年3月)和XBB(第九波,2023年4月至12月)。通过快速抗原检测诊断COVID-19。结果:46,719例儿科急诊科就诊中,COVID-19病例4,085例;第六、七、八、九波确诊病例分别为599例(9.0%)、2943例(15.4%)、543例(2.6%)。与BA.5/BQ组相比,XBB期咳嗽频率明显高于其他时期,流鼻液发生率明显高于其他时期。1期。BA.5/BQ组呕吐发生率较高。1周期比在BA.1/BA。2期。结论:本研究比较了BA.1/BA的儿童COVID-19病例。2, BA.5 / BQ。1、XBB波。虽然XBB波的证据仍然有限,但在此期间观察到的上呼吸道症状,如鼻溢液和咳嗽更为频繁。根据变异类型和年龄组,临床表现有明显差异。
{"title":"Pediatric Coronavirus Disease 2019 Clinical Characteristics in a Primary Emergency Medical Center: Comparative Analysis of BA.1/BA.2, BA.5/BQ.1, and XBB Periods.","authors":"Hiroshi Yamaguchi, Tomohiro Sameshima, Kazumichi Fujioka, Tomoko Horinouchi, Yoshitaka Asagai, Hiroki Ohashi, Tomoko Fujikawa, Akihiro Nishimura, Akihiro Tamura, Shingo Ishimori, Kandai Nozu, Masaaki Kugo, Akihito Ishida","doi":"10.1016/j.jiac.2026.102948","DOIUrl":"https://doi.org/10.1016/j.jiac.2026.102948","url":null,"abstract":"<p><strong>Background: </strong>Differences in the clinical manifestation of pediatric coronavirus disease 2019 (COVID-19) across Omicron variants in emergency departments (EDs) remain unclear.</p><p><strong>Patients and methods: </strong>This retrospective observational study characterized the clinical features of pediatric patients with COVID-19 for each variant period at a primary ED in Kobe City, Japan. The variant-dominant periods comprised BA.1/BA.2 (sixth wave, January-June 2022), BA.5/BQ.1 (seventh-eighth waves, July 2022-March 2023), and XBB (ninth wave, April-December 2023). COVID-19 was diagnosed by rapid antigen testing.</p><p><strong>Results: </strong>Among the 46,719 pediatric ED visits, 4,085 were COVID-19 cases; 599 (9.0%), 2,943 (15.4%) and 543 (2.6%) cases were diagnosed in the sixth, seventh-eighth, and ninth waves, respectively. During the XBB period, cough was significantly more frequent than in other periods and nasal discharge was more common compared with the BA.5/BQ.1 period. Vomiting occurred more frequently in the BA.5/BQ.1 period than in the BA.1/BA.2 period. Among children aged <1 year, vomiting was significantly more common during the XBB period. No significant differences were observed between patients aged 1-4 years. Dyspnea was more common in the BA.1/BA.2 than in the BA.5/BQ.1 period. In adolescents, fever occurred more frequently during the BA.5/BQ.1 period.</p><p><strong>Conclusion: </strong>This study compared pediatric COVID-19 cases across the BA.1/BA.2, BA.5/BQ.1, and XBB waves. Although evidence for the XBB wave remains limited, upper respiratory symptoms such as nasal discharge and cough were observed more frequently during this period. Distinct differences in clinical presentations according to variant type and age group were identified.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"102948"},"PeriodicalIF":1.5,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147433405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020: General view of the pathogens' antibacterial susceptibility" [Journal of Infection and Chemotherapy, 29 (2023) 731-743]. “2019-2020年日本化疗学会、日本传染病学会和日本临床微生物学会监测委员会开展的全国细菌性呼吸道病原体监测:病原体抗菌敏感性的一般看法”[感染与化疗杂志,29(2023)731-743]的勘误表。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-07 DOI: 10.1016/j.jiac.2026.102947
Issei Tokimatsu, Tetsuya Matsumoto, Hiroki Tsukada, Yuji Fujikura, Makoto Miki, Yoshitomo Morinaga, Junko Sato, Tomotaro Wakamura, Hiroshi Kiyota, Kazuhiro Tateda, Hideji Yanagisawa, Takaaki Sasaki, Hideki Ikeda, Hiroshi Horikawa, Hiroshi Takahashi, Masafumi Seki, Yoshiaki Mori, Hiroaki Takeda, Daisuke Kurai, Naoki Hasegawa, Yoshifumi Uwamino, Makoto Kudo, Masaki Yamamoto, Yuko Nagano, Sakika Nomura, Takafumi Tetsuka, Miyuki Hosokai, Nobuki Aoki, Yoshihiro Yamamoto, Yoshitsugu Iinuma, Hiroshige Mikamo, Hiroyuki Suematsu, Takaya Maruyama, Atsushi Kawabata, Yoshiko Sugaki, Atsushi Nakamura, Yasunori Fujikawa, Tatsuya Fukumori, Akira Ukimura, Hiroshi Kakeya, Makoto Niki, Koichiro Yoshida, Yoshihiro Kobashi, Hirokazu Tokuyasu, Kazuhiro Yatera, Hiroaki Ikegami, Masaki Fujita, Takemasa Matsumoto, Katsunori Yanagihara, Junichi Matsuda, Kazufumi Hiramatsu, Takashi Shinzato
{"title":"Corrigendum to \"Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020: General view of the pathogens' antibacterial susceptibility\" [Journal of Infection and Chemotherapy, 29 (2023) 731-743].","authors":"Issei Tokimatsu, Tetsuya Matsumoto, Hiroki Tsukada, Yuji Fujikura, Makoto Miki, Yoshitomo Morinaga, Junko Sato, Tomotaro Wakamura, Hiroshi Kiyota, Kazuhiro Tateda, Hideji Yanagisawa, Takaaki Sasaki, Hideki Ikeda, Hiroshi Horikawa, Hiroshi Takahashi, Masafumi Seki, Yoshiaki Mori, Hiroaki Takeda, Daisuke Kurai, Naoki Hasegawa, Yoshifumi Uwamino, Makoto Kudo, Masaki Yamamoto, Yuko Nagano, Sakika Nomura, Takafumi Tetsuka, Miyuki Hosokai, Nobuki Aoki, Yoshihiro Yamamoto, Yoshitsugu Iinuma, Hiroshige Mikamo, Hiroyuki Suematsu, Takaya Maruyama, Atsushi Kawabata, Yoshiko Sugaki, Atsushi Nakamura, Yasunori Fujikawa, Tatsuya Fukumori, Akira Ukimura, Hiroshi Kakeya, Makoto Niki, Koichiro Yoshida, Yoshihiro Kobashi, Hirokazu Tokuyasu, Kazuhiro Yatera, Hiroaki Ikegami, Masaki Fujita, Takemasa Matsumoto, Katsunori Yanagihara, Junichi Matsuda, Kazufumi Hiramatsu, Takashi Shinzato","doi":"10.1016/j.jiac.2026.102947","DOIUrl":"https://doi.org/10.1016/j.jiac.2026.102947","url":null,"abstract":"","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"102947"},"PeriodicalIF":1.5,"publicationDate":"2026-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147389909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence-based gram stain classification: Accuracy and clinical utility in positive blood cultures. 基于人工智能的革兰氏染色分类:阳性血培养的准确性和临床应用。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-05 DOI: 10.1016/j.jiac.2026.102945
Mieko Tokano, Masahiro Kodana, Norihito Tarumoto, Sakaru Koizumi, Toru Kawamura, Kazuo Imai, Kana Ogane, Shintaro Ichimura, Masaru Matsuoka, Hideki Makabe, Shigefumi Maesaki, Takuya Maeda

Introduction: With the rapid advancement of artificial intelligence (AI) technology, AI has been applied to the detection of pathogens that cause infectious diseases. This study evaluated the newly developed AI-based software, the BiTTE-iE, based on Gram-stained specimen images captured with smartphones, assessing not only its ability to accurately identify bacterial species but also its capability to classify pathogens morphologically.

Methods: Gram-stained slides were prepared from 177 positive blood culture bottles as part of routine clinical practice. This study evaluated the match rate between the results of "Major Pathogen Classification" (GPCs, GPRs, GNCs, GNRs, and Yeast) performed by the BiTTE-iE and the microscopic findings of microbiology-trained medical technologists. Furthermore, the match rate between the pathogen classifications identified by the BiTTE-iE at the "Group-level" and "Species-level" and the final species identification results obtained using culture methods and MALDI-TOF MS was evaluated.

Results: Overall, the match rate for the "Major Pathogen Classification" exceeded 85% in all classification categories except GNCs, where data collection was impossible. For GPCs, a high match rate of 93.8% (166/177) was observed. In contrast, the match rate for "Species-level" classification was relatively low, generally ranging from 0% to 80%. In particular, the match rates for Enterococcus spp. and non-fermentative Gram-negative rods were especially low, resulting in an overall "Species-level" match rate of 41.5% (66/159).

Conclusions: The BiTTE-iE demonstrated potential utility in selecting antimicrobial agents for empirical treatment. By comprehensively accumulating image data for all microbials, it is expected that diagnostic performance using the BiTTE-iE will be further improved.

导读:随着人工智能(AI)技术的快速发展,人工智能已被应用于检测引起传染病的病原体。本研究基于智能手机拍摄的革兰氏染色标本图像,评估了新开发的基于人工智能的软件bite - ie,不仅评估了其准确识别细菌种类的能力,还评估了其对病原体进行形态学分类的能力。方法:对177例阳性血培养瓶进行革兰氏染色。本研究评估了bite - ie进行的“主要病原体分类”(GPCs、GPRs、GNCs、GNRs和酵母菌)结果与受过微生物学培训的医学技术人员的显微镜检查结果之间的匹配率。此外,还对bite - ie在“类群”和“种”水平上鉴定的病原菌分类与培养法和MALDI-TOF MS最终鉴定结果的匹配率进行了评价。结果:总体而言,除GNCs无法收集数据外,“主要病原体分类”的匹配率均超过85%。GPCs的匹配率高达93.8%(166/177)。而“种级”分类的匹配率相对较低,一般在0% ~ 80%之间。其中,肠球菌与非发酵革兰氏阴性棒的匹配率特别低,总体“种级”匹配率为41.5%(66/159)。结论:bite - ie在选择经验性治疗的抗菌药物方面具有潜在的实用性。通过全面积累所有微生物的图像数据,预计使用bite - ie的诊断性能将进一步提高。
{"title":"Artificial intelligence-based gram stain classification: Accuracy and clinical utility in positive blood cultures.","authors":"Mieko Tokano, Masahiro Kodana, Norihito Tarumoto, Sakaru Koizumi, Toru Kawamura, Kazuo Imai, Kana Ogane, Shintaro Ichimura, Masaru Matsuoka, Hideki Makabe, Shigefumi Maesaki, Takuya Maeda","doi":"10.1016/j.jiac.2026.102945","DOIUrl":"10.1016/j.jiac.2026.102945","url":null,"abstract":"<p><strong>Introduction: </strong>With the rapid advancement of artificial intelligence (AI) technology, AI has been applied to the detection of pathogens that cause infectious diseases. This study evaluated the newly developed AI-based software, the BiTTE-iE, based on Gram-stained specimen images captured with smartphones, assessing not only its ability to accurately identify bacterial species but also its capability to classify pathogens morphologically.</p><p><strong>Methods: </strong>Gram-stained slides were prepared from 177 positive blood culture bottles as part of routine clinical practice. This study evaluated the match rate between the results of \"Major Pathogen Classification\" (GPCs, GPRs, GNCs, GNRs, and Yeast) performed by the BiTTE-iE and the microscopic findings of microbiology-trained medical technologists. Furthermore, the match rate between the pathogen classifications identified by the BiTTE-iE at the \"Group-level\" and \"Species-level\" and the final species identification results obtained using culture methods and MALDI-TOF MS was evaluated.</p><p><strong>Results: </strong>Overall, the match rate for the \"Major Pathogen Classification\" exceeded 85% in all classification categories except GNCs, where data collection was impossible. For GPCs, a high match rate of 93.8% (166/177) was observed. In contrast, the match rate for \"Species-level\" classification was relatively low, generally ranging from 0% to 80%. In particular, the match rates for Enterococcus spp. and non-fermentative Gram-negative rods were especially low, resulting in an overall \"Species-level\" match rate of 41.5% (66/159).</p><p><strong>Conclusions: </strong>The BiTTE-iE demonstrated potential utility in selecting antimicrobial agents for empirical treatment. By comprehensively accumulating image data for all microbials, it is expected that diagnostic performance using the BiTTE-iE will be further improved.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"102945"},"PeriodicalIF":1.5,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147372742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyogenic spondylitis and bilateral psoas abscess caused by Streptococcus agalactiae sequence type 283: A case acquired in Vietnam prior to the 2015 Singapore outbreak. 283型无乳链球菌引起的化脓性脊柱炎和双侧腰肌脓肿:2015年新加坡疫情爆发前在越南获得的一例
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-03 DOI: 10.1016/j.jiac.2026.102940
Hiroki Kitagawa, Satoshi Nakano, Kayoko Tadera, Shota Koide, Shogo Otake, Yo Sugawara, Yukihiro Akeda, Motoyuki Sugai, Hiroki Ohge

Streptococcus agalactiae sequence type (ST) 283 is an emerging, hypervirulent lineage predominantly identified in Southeast Asia and strongly associated with foodborne transmission linked to raw freshwater fish consumption. While ST283 was responsible for the 2015 outbreak in Singapore, no human infections have been reported in Japan to date. We describe a travel-associated case of invasive ST283 disease in a Japanese man residing in Vietnam in 2010, representing the earliest documented S. agalactiae ST283 infection in a Japanese individual. A 67-year-old previously healthy man developed progressive lower back pain and fever while living in Vietnam and presented to our institution nine days after symptom onset. Computed tomography and magnetic resonance imaging revealed L2-L3 pyogenic spondylitis with bilateral psoas abscesses. Blood cultures grew S. agalactiae susceptible to β-lactams, and targeted intravenous penicillin followed by ampicillin resulted in complete clinical and radiological resolution after six weeks of therapy. Whole-genome sequencing of the bloodstream isolate demonstrated serotype III-ST283 harboring tetM, pilus islands 1 and 2a, AlphaC, and Srr1. Phylogenetic comparison with a publicly available regional dataset showed close relatedness to isolates recovered in Vietnam during 2015-2016, supporting local acquisition in Vietnam in 2010, predating the 2015 Singapore outbreak. This case highlights that ST283 infections may occur outside recognized endemic settings and may be imported into non-prevalent countries through international travel. Clinicians should consider ST283 in invasive S. agalactiae infections with meningoencephalitis, septic arthritis, and/or spinal infections among travelers returning from Southeast Asia and obtain relevant exposure histories, including consumption of raw/undercooked freshwater fish.

无乳链球菌序列型(ST) 283是一种新兴的高毒力谱系,主要在东南亚发现,与食用生淡水鱼相关的食源性传播密切相关。虽然ST283是2015年新加坡疫情的罪魁祸首,但迄今为止日本尚未报告人类感染。我们描述了2010年居住在越南的一名日本男子发生的与旅行相关的侵袭性ST283疾病病例,代表了日本个体中最早记录的无乳链球菌ST283感染。一名67岁的健康男性在越南居住期间出现进行性腰痛和发烧,并在症状出现9天后来到我们的机构。计算机断层扫描和磁共振成像显示L2-L3化脓性脊柱炎伴双侧腰肌脓肿。血液培养培养出对β-内酰胺敏感的无乳链球菌,靶向静脉注射青霉素后再用氨苄西林治疗6周后,临床和放射学完全消退。血液分离物的全基因组测序显示血清型III-ST283含有tetM、毛菌岛1和2a、AlphaC和Srr1。与公开区域数据集的系统发育比较显示,与2015-2016年在越南发现的分离株密切相关,这支持了2010年在越南当地获得的分离株,即2015年新加坡疫情爆发之前。该病例突出表明,ST283感染可能发生在公认的流行环境之外,并可能通过国际旅行输入到非流行国家。临床医生应将ST283诊断为侵袭性无乳链球菌感染并伴有脑膜脑炎、化脓性关节炎和/或脊柱感染的病例,并获取相关暴露史,包括食用生的/未煮熟的淡水鱼。
{"title":"Pyogenic spondylitis and bilateral psoas abscess caused by Streptococcus agalactiae sequence type 283: A case acquired in Vietnam prior to the 2015 Singapore outbreak.","authors":"Hiroki Kitagawa, Satoshi Nakano, Kayoko Tadera, Shota Koide, Shogo Otake, Yo Sugawara, Yukihiro Akeda, Motoyuki Sugai, Hiroki Ohge","doi":"10.1016/j.jiac.2026.102940","DOIUrl":"https://doi.org/10.1016/j.jiac.2026.102940","url":null,"abstract":"<p><p>Streptococcus agalactiae sequence type (ST) 283 is an emerging, hypervirulent lineage predominantly identified in Southeast Asia and strongly associated with foodborne transmission linked to raw freshwater fish consumption. While ST283 was responsible for the 2015 outbreak in Singapore, no human infections have been reported in Japan to date. We describe a travel-associated case of invasive ST283 disease in a Japanese man residing in Vietnam in 2010, representing the earliest documented S. agalactiae ST283 infection in a Japanese individual. A 67-year-old previously healthy man developed progressive lower back pain and fever while living in Vietnam and presented to our institution nine days after symptom onset. Computed tomography and magnetic resonance imaging revealed L2-L3 pyogenic spondylitis with bilateral psoas abscesses. Blood cultures grew S. agalactiae susceptible to β-lactams, and targeted intravenous penicillin followed by ampicillin resulted in complete clinical and radiological resolution after six weeks of therapy. Whole-genome sequencing of the bloodstream isolate demonstrated serotype III-ST283 harboring tetM, pilus islands 1 and 2a, AlphaC, and Srr1. Phylogenetic comparison with a publicly available regional dataset showed close relatedness to isolates recovered in Vietnam during 2015-2016, supporting local acquisition in Vietnam in 2010, predating the 2015 Singapore outbreak. This case highlights that ST283 infections may occur outside recognized endemic settings and may be imported into non-prevalent countries through international travel. Clinicians should consider ST283 in invasive S. agalactiae infections with meningoencephalitis, septic arthritis, and/or spinal infections among travelers returning from Southeast Asia and obtain relevant exposure histories, including consumption of raw/undercooked freshwater fish.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"102940"},"PeriodicalIF":1.5,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147365442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical pharmacist-led implementation of an intravenous-to-oral antimicrobial switch protocol: A prospective Quasi-experimental study 临床药师主导的静脉到口服抗菌药物切换方案的实施:一项前瞻性准实验研究。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-02-06 DOI: 10.1016/j.jiac.2026.102925
Fatma Gul Yumrucu , Emre Kara , Leyla Yumrukaya , Hatice Yagmur Zengin , Selen Yegenoglu , Ahmet Cagkan Inkaya , Gokhan Metan , Omrum Uzun

Objectives

In antimicrobial therapy, early intravenous-to-oral switch (IVOS) is recommended for eligible patients to minimize complications and optimize pharmacoeconomic outcomes. This study aimed to evaluate the impact of a clinical pharmacist-led multimodal intervention strategy on IVOS rates.

Methods

A prospective before-and-after study was conducted between January and June 2024, including observation and intervention periods. Hospitalized adults receiving IV antimicrobials were included. A two-round expert panel was convened prior to data collection to identify the criteria for IVOS. During the observation period, IV antimicrobial utilization patterns were monitored without intervention. The intervention period involved the implementation of a standardized IVOS protocol, targeted education for infectious disease physicians, and switch recommendations for eligible treatments. The primary endpoint was the difference in IVOS rates between study periods among eligible treatments.

Results

Among 962 IV antimicrobial courses evaluated, 213 (22.1%) met the eligibility criteria for IVOS. Among patients who met IVOS eligibility criteria, the proportion undergoing overall IVOS increased from 29.0% in the observation period to 54.0% in the intervention period (p < 0.001). Among 113 IVOS-eligible cases, pharmacists recommended switching in 57 (50.4%), with a 59.6% physician acceptance rate (34/57). No significant differences were observed between periods for: microbiological cure rates, Clostridioides difficile infection incidence, intensive care unit admission rates, antimicrobial reinitiation within 48 h of treatment cessation, 15- and 30-day readmission and mortality rates. Antimicrobial costs decreased significantly from $15,600.30 (all-parenteral baseline) and $14,997.40 (adjusted baseline) to $8333.81 post intervention.

Conclusions

The intervention was associated with a substantial increase in overall IVOS among eligible patients, supporting its effectiveness in promoting timely de-escalation from intravenous therapy. Clinical pharmacist-led initiatives optimize appropriate switching and antimicrobial utilization in stewardship.
目的:在抗菌药物治疗中,建议符合条件的患者早期静脉转口服切换(IVOS),以尽量减少并发症并优化药物经济学结果。本研究旨在评估临床药师主导的多模式干预策略对IVOS发生率的影响。方法:于2024年1 - 6月进行前瞻性前后对照研究,包括观察期和干预期。接受静脉注射抗微生物药物的住院成年人也包括在内。在收集数据之前召开了两轮专家小组会议,以确定ivs的标准。在观察期间,在不干预的情况下监测静脉抗菌药物的使用情况。干预期间包括实施标准化的IVOS方案,对传染病医生进行有针对性的教育,并对符合条件的治疗方法提出建议。主要终点是在符合条件的治疗中,研究期间IVOS率的差异。结果:962个静脉抗菌疗程中,213个疗程(22.1%)符合IVOS标准。在符合IVOS资格标准的患者中,接受总IVOS的比例从观察期的29.0%增加到干预期的54.0% (p结论:干预与符合条件的患者中总IVOS的大幅增加相关,支持其在促进静脉治疗及时降级方面的有效性。临床药师主导的举措优化适当的切换和抗菌药物的使用管理。
{"title":"Clinical pharmacist-led implementation of an intravenous-to-oral antimicrobial switch protocol: A prospective Quasi-experimental study","authors":"Fatma Gul Yumrucu ,&nbsp;Emre Kara ,&nbsp;Leyla Yumrukaya ,&nbsp;Hatice Yagmur Zengin ,&nbsp;Selen Yegenoglu ,&nbsp;Ahmet Cagkan Inkaya ,&nbsp;Gokhan Metan ,&nbsp;Omrum Uzun","doi":"10.1016/j.jiac.2026.102925","DOIUrl":"10.1016/j.jiac.2026.102925","url":null,"abstract":"<div><h3>Objectives</h3><div>In antimicrobial therapy, early intravenous-to-oral switch (IVOS) is recommended for eligible patients to minimize complications and optimize pharmacoeconomic outcomes. This study aimed to evaluate the impact of a clinical pharmacist-led multimodal intervention strategy on IVOS rates.</div></div><div><h3>Methods</h3><div>A prospective before-and-after study was conducted between January and June 2024, including observation and intervention periods. Hospitalized adults receiving IV antimicrobials were included. A two-round expert panel was convened prior to data collection to identify the criteria for IVOS. During the observation period, IV antimicrobial utilization patterns were monitored without intervention. The intervention period involved the implementation of a standardized IVOS protocol, targeted education for infectious disease physicians, and switch recommendations for eligible treatments. The primary endpoint was the difference in IVOS rates between study periods among eligible treatments.</div></div><div><h3>Results</h3><div>Among 962 IV antimicrobial courses evaluated, 213 (22.1%) met the eligibility criteria for IVOS. Among patients who met IVOS eligibility criteria, the proportion undergoing overall IVOS increased from 29.0% in the observation period to 54.0% in the intervention period (p &lt; 0.001). Among 113 IVOS-eligible cases, pharmacists recommended switching in 57 (50.4%), with a 59.6% physician acceptance rate (34/57). No significant differences were observed between periods for: microbiological cure rates, <em>Clostridioides difficile</em> infection incidence, intensive care unit admission rates, antimicrobial reinitiation within 48 h of treatment cessation, 15- and 30-day readmission and mortality rates. Antimicrobial costs decreased significantly from $15,600.30 (all-parenteral baseline) and $14,997.40 (adjusted baseline) to $8333.81 post intervention.</div></div><div><h3>Conclusions</h3><div>The intervention was associated with a substantial increase in overall IVOS among eligible patients, supporting its effectiveness in promoting timely de-escalation from intravenous therapy. Clinical pharmacist-led initiatives optimize appropriate switching and antimicrobial utilization in stewardship.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 3","pages":"Article 102925"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of recombinant human thrombomodulin in a pediatric case of COVID-19–associated coagulopathy: A case report 重组人血栓调节蛋白在小儿covid -19相关凝血病中的应用:1例报告
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-02-09 DOI: 10.1016/j.jiac.2026.102926
Fumihiro Ochi , Kozo Nagai , Shiori Ukita , Ayuko Yoshida , Mika Kawabe , Tomozo Moritani , Naoko Nakano , Eiichi Yamamoto , Hisamichi Tauchi
Coronavirus disease 2019 (COVID-19)–associated coagulopathy (CAC) is a known extrapulmonary complication of severe acute respiratory syndrome coronavirus 2 infection, primarily studied in adults. As a result, pediatric data are limited, and management strategies remain under investigation. Recombinant human soluble thrombomodulin (rh-TM), an anticoagulant with anti-inflammatory and antifibrinolytic properties, has shown promise in sepsis-induced coagulopathy; however, it has not been widely studied in children with CAC. A previously healthy 5-year-old girl presented with severe CAC secondary to COVID-19. She initially presented with persistent fever, gastrointestinal and respiratory symptoms, and gingival bleeding. Laboratory evaluation revealed significant coagulopathy characterized by high D-dimer (≥110.3 μg/mL), fibrinogen/fibrin degradation products (328.6 μg/mL), thrombin–antithrombin complex (≥120 ng/mL), and plasmin–α2 plasmin inhibitor complex (7.7 μg/mL), along with thrombocytopenia and prolonged prothrombin time and international normalized ratio and activated partial thromboplastin time. Imaging showed ground-glass opacities on chest computed tomography (CT) and increased 18F-fluorodeoxyglucose uptake in positron emission tomography–CT. A multidisciplinary treatment regimen was initiated, including intravenous immunoglobulin, remdesivir, rh-TM, corticosteroids, low-dose aspirin, and budesonide inhalation. Levels of coagulation markers gradually normalized, and the patient's clinical symptoms resolved without further complications. She was discharged on day 29 of illness and remained relapse-free after 1 year of follow-up. This case highlights the potential utility of rh-TM as part of a tailored multimodal treatment strategy for pediatric CAC. Early recognition and individualized, stage-specific therapy may contribute to favorable outcomes. However, further studies are warranted to evaluate the safety and efficacy of rh-TM in children with CAC.
冠状病毒病2019 (COVID-19)相关凝血功能障碍(CAC)是一种已知的严重急性呼吸综合征冠状病毒2感染的肺外并发症,主要在成人中进行研究。因此,儿科数据有限,管理策略仍在调查中。重组人可溶性凝血调节蛋白(rh-TM)是一种具有抗炎和抗纤溶特性的抗凝血剂,在脓毒症诱导的凝血病中显示出前景;然而,在患有CAC的儿童中尚未进行广泛的研究。先前健康的5岁女孩出现继发于COVID-19的严重CAC。她最初表现为持续发热、胃肠道和呼吸道症状以及牙龈出血。实验室评估显示明显的凝血功能障碍,其特征为高d -二聚体(≥110.3 μg/mL),纤维蛋白原/纤维蛋白降解产物(328.6 μg/mL),凝血酶-抗凝血酶复合物(≥120 ng/mL),纤溶酶-α2纤溶酶抑制剂复合物(7.7 μg/mL),伴血小板减少,凝血酶原时间延长,国际标准化比例延长,部分凝血活蛋白活化时间延长。胸部CT显示磨玻璃影,正电子发射CT显示18f -氟脱氧葡萄糖摄取增加。开始了多学科治疗方案,包括静脉注射免疫球蛋白、瑞德西韦、rh-TM、皮质类固醇、低剂量阿司匹林和布地奈德吸入。凝血指标水平逐渐恢复正常,患者临床症状消失,无进一步并发症。患者于发病第29天出院,随访1年无复发。本病例强调了rh-TM作为儿科CAC量身定制的多模式治疗策略的一部分的潜在效用。早期识别和个体化、分期治疗可能有助于获得良好的结果。然而,需要进一步的研究来评估rh-TM治疗CAC患儿的安全性和有效性。
{"title":"Use of recombinant human thrombomodulin in a pediatric case of COVID-19–associated coagulopathy: A case report","authors":"Fumihiro Ochi ,&nbsp;Kozo Nagai ,&nbsp;Shiori Ukita ,&nbsp;Ayuko Yoshida ,&nbsp;Mika Kawabe ,&nbsp;Tomozo Moritani ,&nbsp;Naoko Nakano ,&nbsp;Eiichi Yamamoto ,&nbsp;Hisamichi Tauchi","doi":"10.1016/j.jiac.2026.102926","DOIUrl":"10.1016/j.jiac.2026.102926","url":null,"abstract":"<div><div>Coronavirus disease 2019 (COVID-19)–associated coagulopathy (CAC) is a known extrapulmonary complication of severe acute respiratory syndrome coronavirus 2 infection, primarily studied in adults. As a result, pediatric data are limited, and management strategies remain under investigation. Recombinant human soluble thrombomodulin (rh-TM), an anticoagulant with anti-inflammatory and antifibrinolytic properties, has shown promise in sepsis-induced coagulopathy; however, it has not been widely studied in children with CAC. A previously healthy 5-year-old girl presented with severe CAC secondary to COVID-19. She initially presented with persistent fever, gastrointestinal and respiratory symptoms, and gingival bleeding. Laboratory evaluation revealed significant coagulopathy characterized by high D-dimer (≥110.3 μg/mL), fibrinogen/fibrin degradation products (328.6 μg/mL), thrombin–antithrombin complex (≥120 ng/mL), and plasmin–α2 plasmin inhibitor complex (7.7 μg/mL), along with thrombocytopenia and prolonged prothrombin time and international normalized ratio and activated partial thromboplastin time. Imaging showed ground-glass opacities on chest computed tomography (CT) and increased <sup>18</sup>F-fluorodeoxyglucose uptake in positron emission tomography–CT. A multidisciplinary treatment regimen was initiated, including intravenous immunoglobulin, remdesivir, rh-TM, corticosteroids, low-dose aspirin, and budesonide inhalation. Levels of coagulation markers gradually normalized, and the patient's clinical symptoms resolved without further complications. She was discharged on day 29 of illness and remained relapse-free after 1 year of follow-up. This case highlights the potential utility of rh-TM as part of a tailored multimodal treatment strategy for pediatric CAC. Early recognition and individualized, stage-specific therapy may contribute to favorable outcomes. However, further studies are warranted to evaluate the safety and efficacy of rh-TM in children with CAC.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 3","pages":"Article 102926"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced guideline-compliant antimicrobial prophylaxis based on preoperative urine culture pathogens reduces bloodstream infection and sepsis following ureteroscopic lithotripsy 基于术前尿培养病原体的强化符合指南的抗菌预防可减少输尿管镜碎石术后的血流感染和败血症。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-02-06 DOI: 10.1016/j.jiac.2026.102924
Katsuhiro Onishi , Hiroshi Morioka , Masashi Yamamoto , Daisuke Tsuchimoto , Mitsuru Nishio , Yoshie Moriya , Toru Kimura

Introduction

Positive preoperative urine culture is a risk factor for infection after ureteroscopic lithotripsy (URSL). However, the effectiveness of tailoring antimicrobial prophylaxis (AP) to pathogens identified in preoperative urine culture remains unclear. This study aimed to evaluate whether three AP strategies reduce bloodstream infections and sepsis following URSL.

Methods

This single-center retrospective observational study was conducted between April 2019 and March 2025 at Komaki City Hospital, Japan. AP was classified into three categories: guideline-compliant AP (GC-AP, which do not cover all detected pathogens), pathogen-directed AP (PD-AP, which cover all pathogens but is non-guideline-compliant), and enhanced GC-AP (GC-AP or AP with an extended spectrum of antibiotics to which all pathogens detected in the preoperative urine culture are susceptible). The incidences of bloodstream infections and sepsis after URSL were compared among the three groups. The risk factors for postoperative sepsis were analyzed using multivariable logistic analysis.

Results

The enhanced GC-AP group had fewer bloodstream infections than the GC-AP group (0.67% [1/149] vs. 8.11% [6/74], p = 0.0059). No bloodstream infections were observed in the PD-AP group. However, the incidence of sepsis was significantly higher in the PD-AP group than in the enhanced GC-AP group (28.6% [8/28] vs. 10.7% [16/149], p = 0.030). Multivariable analysis showed that enhanced GC-AP significantly reduced the incidence of sepsis after URSL (odds ratio: 0.41, 95% confidence interval: 0.18–0.93, p = 0.023).

Conclusions

Enhanced GC-AP reduced bloodstream infections and sepsis after URSL.
导读:术前尿培养阳性是输尿管镜碎石术(URSL)后感染的危险因素。然而,针对术前尿培养中发现的病原体定制抗菌素预防(AP)的有效性尚不清楚。本研究旨在评估三种AP策略是否能减少URSL后的血流感染和脓毒症。方法:这项单中心回顾性观察研究于2019年4月至2025年3月在日本小木市医院进行。AP分为三类:符合指南的AP (GC-AP,不包括所有检测到的病原体),病原体定向AP (PD-AP,涵盖所有病原体,但不符合指南),增强型GC-AP (GC-AP或具有扩展抗生素谱的AP,术前尿培养中检测到的所有病原体都对其敏感)。比较三组患者URSL后血流感染和脓毒症的发生率。采用多变量logistic分析分析术后脓毒症的危险因素。结果:增强GC-AP组血流感染发生率低于GC-AP组(0.67% [1/149]vs. 8.11% [6/74], p = 0.0059)。PD-AP组未见血流感染。但PD-AP组脓毒症发生率明显高于增强GC-AP组(28.6%[8/28]比10.7% [16/149],p = 0.030)。多变量分析显示,增强的GC-AP可显著降低URSL后脓毒症的发生率(优势比:0.41,95%可信区间:0.18-0.93,p = 0.023)。结论:增强GC-AP可减少URSL后的血流感染和脓毒症。
{"title":"Enhanced guideline-compliant antimicrobial prophylaxis based on preoperative urine culture pathogens reduces bloodstream infection and sepsis following ureteroscopic lithotripsy","authors":"Katsuhiro Onishi ,&nbsp;Hiroshi Morioka ,&nbsp;Masashi Yamamoto ,&nbsp;Daisuke Tsuchimoto ,&nbsp;Mitsuru Nishio ,&nbsp;Yoshie Moriya ,&nbsp;Toru Kimura","doi":"10.1016/j.jiac.2026.102924","DOIUrl":"10.1016/j.jiac.2026.102924","url":null,"abstract":"<div><h3>Introduction</h3><div>Positive preoperative urine culture is a risk factor for infection after ureteroscopic lithotripsy (URSL). However, the effectiveness of tailoring antimicrobial prophylaxis (AP) to pathogens identified in preoperative urine culture remains unclear. This study aimed to evaluate whether three AP strategies reduce bloodstream infections and sepsis following URSL.</div></div><div><h3>Methods</h3><div>This single-center retrospective observational study was conducted between April 2019 and March 2025 at Komaki City Hospital, Japan. AP was classified into three categories: guideline-compliant AP (GC-AP, which do not cover all detected pathogens), pathogen-directed AP (PD-AP, which cover all pathogens but is non-guideline-compliant), and enhanced GC-AP (GC-AP or AP with an extended spectrum of antibiotics to which all pathogens detected in the preoperative urine culture are susceptible). The incidences of bloodstream infections and sepsis after URSL were compared among the three groups. The risk factors for postoperative sepsis were analyzed using multivariable logistic analysis.</div></div><div><h3>Results</h3><div>The enhanced GC-AP group had fewer bloodstream infections than the GC-AP group (0.67% [1/149] vs. 8.11% [6/74], p = 0.0059). No bloodstream infections were observed in the PD-AP group. However, the incidence of sepsis was significantly higher in the PD-AP group than in the enhanced GC-AP group (28.6% [8/28] vs. 10.7% [16/149], p = 0.030). Multivariable analysis showed that enhanced GC-AP significantly reduced the incidence of sepsis after URSL (odds ratio: 0.41, 95% confidence interval: 0.18–0.93, p = 0.023).</div></div><div><h3>Conclusions</h3><div>Enhanced GC-AP reduced bloodstream infections and sepsis after URSL.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 3","pages":"Article 102924"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed Cutibacterium acnes infection of a thoracic aortic graft presenting as empyema: A case report and literature review 胸主动脉移植物迟发性痤疮表皮杆菌感染表现为脓胸:1例报告并文献复习。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-02-04 DOI: 10.1016/j.jiac.2026.102922
Jun Taguchi , Hiroshi Morioka , Yoshiyuki Tokuda , Tomonari Uemura , Hiroshi Hamada , Ken-ichi Iwata , Kohei Kanda , Keisuke Oka , Tetsuya Yagi
Cutibacterium acnes is a low-virulence skin commensal that can cause late-onset prosthetic graft infections. We report the case of a 60-year-old man with diabetes who presented with fever and bilateral chest pain 10 months after an ascending aortic graft replacement. Computed tomography revealed right-sided pleural effusion and perigraft fluid collections; extended incubation of the pleural fluid and blood samples revealed C. acnes. Seven weeks after the intravenous antibiotic therapy, the patient underwent mediastinal irrigation, explantation of the infected graft, replacement with a rifampicin-soaked prosthesis, and omental flap coverage. Extended incubation of intraoperative specimens resulted in C. acnes in both samples. Following four additional weeks of intravenous antibiotic therapy, long-term oral amoxicillin suppression was initiated. At one-year follow-up, the patient remained clinically stable without evidence of recurrence. This case highlights the importance of extended incubation, vigilant diagnostic evaluation, and combined surgical and antimicrobial management in delayed C. acnes vascular graft infections. We also reviewed relevant literature on C. acnes prosthetic vascular infections to contextualize this case.
痤疮表皮杆菌是一种低毒力的皮肤共生菌,可引起迟发性假体移植物感染。我们报告的情况下,60岁的男性糖尿病谁提出发烧和双侧胸痛10个月后,升主动脉移植物更换。计算机断层扫描显示右侧胸腔积液和周围积液;胸腔液和血液样本的长期孵育显示有痤疮球菌。静脉抗生素治疗7周后,患者接受纵隔冲洗,移植感染的移植物,用利福平浸泡的假体置换,并覆盖大网膜瓣。术中标本的长时间孵育导致两个样本中都有痤疮芽孢杆菌。在额外的4周静脉抗生素治疗后,开始长期口服阿莫西林抑制。在一年的随访中,患者保持临床稳定,无复发迹象。本病例强调了延迟性痤疮C.血管移植物感染的延长潜伏期、警惕诊断评估以及外科和抗菌药物联合管理的重要性。我们还回顾了有关痤疮假体血管感染的相关文献,以了解本病例的背景。
{"title":"Delayed Cutibacterium acnes infection of a thoracic aortic graft presenting as empyema: A case report and literature review","authors":"Jun Taguchi ,&nbsp;Hiroshi Morioka ,&nbsp;Yoshiyuki Tokuda ,&nbsp;Tomonari Uemura ,&nbsp;Hiroshi Hamada ,&nbsp;Ken-ichi Iwata ,&nbsp;Kohei Kanda ,&nbsp;Keisuke Oka ,&nbsp;Tetsuya Yagi","doi":"10.1016/j.jiac.2026.102922","DOIUrl":"10.1016/j.jiac.2026.102922","url":null,"abstract":"<div><div><em>Cutibacterium acnes</em> is a low-virulence skin commensal that can cause late-onset prosthetic graft infections. We report the case of a 60-year-old man with diabetes who presented with fever and bilateral chest pain 10 months after an ascending aortic graft replacement. Computed tomography revealed right-sided pleural effusion and perigraft fluid collections; extended incubation of the pleural fluid and blood samples revealed <em>C. acnes</em>. Seven weeks after the intravenous antibiotic therapy, the patient underwent mediastinal irrigation, explantation of the infected graft, replacement with a rifampicin-soaked prosthesis, and omental flap coverage. Extended incubation of intraoperative specimens resulted in <em>C. acnes</em> in both samples. Following four additional weeks of intravenous antibiotic therapy, long-term oral amoxicillin suppression was initiated. At one-year follow-up, the patient remained clinically stable without evidence of recurrence. This case highlights the importance of extended incubation, vigilant diagnostic evaluation, and combined surgical and antimicrobial management in delayed <em>C. acnes</em> vascular graft infections. We also reviewed relevant literature on <em>C. acne</em>s prosthetic vascular infections to contextualize this case.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 3","pages":"Article 102922"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on “In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan” 对“头孢地罗在日本对碳青霉烯耐药革兰氏阴性病原菌的体外活性”的评论。
IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-02-17 DOI: 10.1016/j.jiac.2026.102933
Sakura Ogawa , Shinnosuke Fukushima , Mari Yamamoto , Shuma Tsuji , Kazuyoshi Gotoh , Hideharu Hagiya
{"title":"Comments on “In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan”","authors":"Sakura Ogawa ,&nbsp;Shinnosuke Fukushima ,&nbsp;Mari Yamamoto ,&nbsp;Shuma Tsuji ,&nbsp;Kazuyoshi Gotoh ,&nbsp;Hideharu Hagiya","doi":"10.1016/j.jiac.2026.102933","DOIUrl":"10.1016/j.jiac.2026.102933","url":null,"abstract":"","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 3","pages":"Article 102933"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146219998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection and Chemotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1